Can Ben Lamm save the planet? He thinks so. Short, stocky and unassuming with a puckish sense of humor, the shaggy-haired ...

Cambiaso has changed the way polo works. Not only through his skill and tactical genius, but as a result of a bet he made ...

Equity Insider News Commentary, The immuno-oncology market is forecast to grow from $65.22 billion in 2025 to $170.19 billion by 2032, fueled by checkpoint inhibitors, CAR-T cell therapy, and cancer ...

ADRIAN WOOLFSON, scientist and founder of Genyro, has authored a brave new book, 'On the Future of Species'. Here, Woolfson examines with SUCHETA DASGUPTA the future of humanity in a world of AI ...

An innovative clinical trial examining whether robotic companion pets can improve the outcomes of hospitalized older adults with dementia has delivered meaningful results that have far-reaching ...

Zoetis, Inc. ZTS is expected to beat expectations when it reports its fourth-quarter 2025 earnings on Feb. 12, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported ...

CRISPR Therapeutics’ fourth quarter was relatively disappointing. As a biotech start-up still in its infancy though, these early quarterly numbers don’t mean much. The foreseeable future looks bright ...

Last year’s federal agency layoffs, grant discontinuations, and university funding cuts led to numerous warnings of the disastrous impact on U.S. science research. Gretchen Goldman, PhD, from the ...

Margret Grebowicz does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...